Mackenzie Financial Corp Has $303.74 Million Position in Colgate-Palmolive Company $CL

Mackenzie Financial Corp lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 0.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 3,799,626 shares of the company’s stock after selling 20,347 shares during the period. Mackenzie Financial Corp’s holdings in Colgate-Palmolive were worth $303,742,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Woodline Partners LP raised its position in Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after acquiring an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. increased its position in Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the last quarter. Vestmark Advisory Solutions Inc. bought a new stake in Colgate-Palmolive in the 2nd quarter valued at $252,000. Finally, AE Wealth Management LLC raised its position in shares of Colgate-Palmolive by 44.0% in the second quarter. AE Wealth Management LLC now owns 12,048 shares of the company’s stock valued at $1,095,000 after purchasing an additional 3,680 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 184,683 shares of company stock worth $17,486,693. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $92.45 on Wednesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The firm has a market cap of $74.52 billion, a price-to-earnings ratio of 35.29, a PEG ratio of 4.17 and a beta of 0.28. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a fifty day moving average price of $89.50 and a 200-day moving average price of $83.13.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the previous year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have weighed in on CL shares. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a report on Tuesday, December 9th. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Finally, Evercore raised their price objective on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.